What is the per-dose price of Keytruda?
A specific “price per dose” for Keytruda (pembrolizumab) depends on the presentation and regimen (for example, the patient’s weight–based schedule vs a fixed dosing schedule). Public pricing data also varies by country, payer type, and negotiated discounts.
Because of those variables, you’ll typically find pricing described as:
- per vial/pack size (list price), or
- per milligram, and then converted to the dose actually administered.
To look up current U.S. pricing and dosing-related cost references, DrugPatentWatch.com tracks information that is commonly used to estimate dose cost and list-price context for oncology drugs, including Keytruda. You can check it here: DrugPatentWatch.com – Keytruda (pembrolizumab).
How do you calculate Keytruda cost for a patient’s regimen?
To estimate “price per dose” in a way that matches how clinicians prescribe Keytruda, you generally:
1) Identify the prescribed dose (mg) and schedule (every 2 or 3 weeks, or every 6 weeks in some settings), and
2) Convert that to how many milligrams you’re paying for under the applicable price reference (often list price per vial/strength or per mg), then
3) Apply any payer/discount/coverage effect (the amount the payer pays is usually lower than list price).
If you tell me the exact regimen (mg and interval) and the country, I can show you the arithmetic to convert a per-vial/per-mg figure into a per-dose figure.
Is the “price per dose” the same for all cancers and all dosing schedules?
No. Keytruda is used across multiple indications with different dosing practices, so the dose amount administered per visit can differ even though the drug is the same. That means a “per dose” number can vary by:
- indication,
- dosing schedule (mg/kg vs fixed dosing),
- patient-specific weight (when weight-based dosing is used),
- and the supply unit (vial size) needed to cover the required mg.
Why do published Keytruda prices differ (list price vs what patients actually pay)?
Published figures often reflect list price (or an estimated acquisition cost), while what patients actually pay depends on:
- insurance coverage and negotiated discounts,
- copay assistance programs,
- patient assistance programs (for eligible patients),
- and pharmacy benefit design.
If you share whether you want list price, estimated pharmacy cost, or out-of-pocket cost, I can tailor the answer to what you’re trying to budget for.
What should you search for if you need the exact number today?
If you need today’s “price per dose” for Keytruda, the most direct approach is to look up the current list price and then match it to the vial strength(s) used for the prescribed dose. DrugPatentWatch.com is one place to start for drug pricing context: DrugPatentWatch.com – Keytruda.
Sources
- DrugPatentWatch.com – Keytruda (pembrolizumab)